{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:49:57Z","timestamp":1779115797997,"version":"3.51.4"},"reference-count":38,"publisher":"Japanese Society of Hypertension","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1291\/hypres.29.285","type":"journal-article","created":{"date-parts":[[2006,6,16]],"date-time":"2006-06-16T05:52:35Z","timestamp":1150437155000},"page":"285-294","source":"Crossref","is-referenced-by-count":20,"title":["Tissue Inhibitor of Metalloproteinase-3 Plays Important Roles in the Kidney Following Unilateral Ureteral Obstruction"],"prefix":"10.1291","volume":"29","author":[{"given":"Hidenobu","family":"KAWAMOTO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"YASUDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"SUZUKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"OZAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamori","family":"YOTSUI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"HIGUCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"RAKUGI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"FUKUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"OGIHARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyo","family":"MAEDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"119","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.191"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01661"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.25.817"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.25.49"},{"issue":"24","key":"5","doi-asserted-by":"crossref","first-page":"17321","DOI":"10.1016\/S0021-9258(18)41928-X","volume":"267","year":"1992","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9258","issn-type":"print"},{"issue":"12","key":"6","doi-asserted-by":"crossref","first-page":"9352","DOI":"10.1016\/S0021-9258(17)37115-6","volume":"269","year":"1994","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9258","issn-type":"print"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fedak PW, Verma S, Weisel RD, Li RK: Cardiac remodeling and failure from molecules to man (Part II). <i>Cardiovasc Pathol<\/i> 2005; <b>14<\/b>: 49-60.","DOI":"10.1016\/j.carpath.2005.01.005"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(98)01031-X"},{"issue":"9","key":"9","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/carcin\/17.9.1805","volume":"17","year":"1996","ISSN":"https:\/\/id.crossref.org\/issn\/0143-3334","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Cruz-Munoz W, Kim I, Khokha R: TIMP-3 deficiency in the host, but not in the tumor, enhances tumor growth and angiogenesis. <i>Oncogene<\/i> 2006; <b>25<\/b>: 650-655.","DOI":"10.1038\/sj.onc.1209104"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690217"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Baker AH, Zaltsman AB, George SJ, Newby AC: Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death <i>in vitro<\/i>. TIMP-3 promotes apoptosis. <i>J Clin Invest<\/i> 1998; <b>101<\/b>: 1478-1487.","DOI":"10.1172\/JCI1584"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M007929200"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1038\/nm846"},{"issue":"4","key":"15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng1294-352","volume":"8","year":"1994","ISSN":"https:\/\/id.crossref.org\/issn\/1061-4036","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Pulido J, Sanders D, Winters JL, Klingel R: Clinical outcomes and mechanism of action for rheopheresis treatment of age-related macular degeneration (AMD). <i>J Clin Apher<\/i> 2005; <b>20<\/b>: 185-194.","DOI":"10.1002\/jca.20047"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Klahr S, Morrissey J: Obstructive nephropathy and renal fibrosis. <i>Am J Physiol Renal Physiol<\/i> 2002; <b>283<\/b>: F861-F875.","DOI":"10.1152\/ajprenal.00362.2001"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Bascands JL, Schanstra JP: Obstructive nephropathy: insights from genetically engineered animals. <i>Kidney Int<\/i> 2005; <b>68<\/b>: 925-937.","DOI":"10.1111\/j.1523-1755.2005.00486.x"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.599"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Oda T, Jung YO, Eddy AA, <i>et al<\/i>: PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. <i>Kidney Int<\/i> 2001; <b>60<\/b>: 587-596.","DOI":"10.1046\/j.1523-1755.2001.030002587.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Engelmyer E, van Goor H, Edwards DR, Diamond JR: Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase-1, -2, and -3 in experimental hydronephrosis. <i>J Am Soc Nephrol<\/i> 1995; <b>5<\/b>: 1675-1683.","DOI":"10.1681\/ASN.V591675"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kim H, Oda T, Lopez-Guisa J, Eddy AA, <i>et al<\/i>: TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy. <i>J Am Soc Nephrol<\/i> 2001; <b>12<\/b>: 736-748.","DOI":"10.1681\/ASN.V124736"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Apte SS, Olsen BR, Murphy G: The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. <i>J Biol Chem<\/i> 1996; <b>271<\/b>: 2874.","DOI":"10.1074\/jbc.270.24.14313"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.17.9067"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00328.x"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.0590041304.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Moriyama T, Kawada N, Hori M, <i>et al<\/i>: Up-regulation of HSP47 in the mouse kidneys with unilateral ureteral obstruction. <i>Kidney Int<\/i> 1998; <b>54<\/b>: 110-119.","DOI":"10.1046\/j.1523-1755.1998.00964.x"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00910.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Muramatsu M, Takai S, Miyazaki M: Detections of matrix metalloproteinases activities and localization by film <i>in situ<\/i> zymography (FIZ). <i>Nippon Yakurigaku Zasshi<\/i> 2003; <b>121<\/b>: 113-118 (in Japanese).","DOI":"10.1254\/fpj.121.113"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000067632.04658.B8"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kuncio GS, Neilson EG, Haverty T: Mechanisms of tubulointerstitial fibrosis. <i>Kidney Int<\/i> 1991; <b>39<\/b>: 550-556.","DOI":"10.1038\/ki.1991.63"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Leco KJ, Waterhouse P, Khokha R, <i>et al<\/i>: Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). <i>J Clin Invest<\/i> 2001; <b>108<\/b>: 817-829.","DOI":"10.1172\/JCI200112067"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Fedak PW, Smookler DS, Khokha R, <i>et al<\/i>: TIMP-3 deficiency leads to dilated cardiomyopathy. <i>Circulation<\/i> 2004; <b>110<\/b>: 2401-2409.","DOI":"10.1161\/01.CIR.0000134959.83967.2D"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.351"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(95)00783-0"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.971"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.303"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Yokoi H, Mukoyama M, Nagae T, <i>et al<\/i>: Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. <i>J Am Soc Nephrol<\/i> 2004; <b>15<\/b>: 1430-1440.","DOI":"10.1097\/01.ASN.0000130565.69170.85"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T12:02:39Z","timestamp":1627473759000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/doifinder\/10.1291\/hypres.29.285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1291\/hypres.29.285","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006]]}}}